Phase 2b Elumina trial; topline data anticipated in Q4 2026 (ClinicalTrials.gov: NCT06524830) AtaiBeckley plans to advance VLS-01 into major depressive disorder (MDD) in Phase 3, with generalized ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Ten years ago, a franchisee reached out for help. His business was failing, and he couldn't find guidance on how to save his dream. So, Aicha Bascaro ? a former pizza delivery driver turned global ...
Plus inc. today announced that John Lutz, a senior executive with more than 30 years' experience across global technology and institutional environments, has joined its Board of ...
Nanobiotechnology is a discipline in which tools from nanotechnology are developed and applied to study biological phenomena. For example, nanoparticles can serve as probes, sensors or vehicles for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results